We are live on
!
Find out more
BCM
Beddow Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
+19%
1 Year Est. Return
+18.36%
3 Year Est. Return
+50.71%
5 Year Est. Return
+107.72%
10 Year Est. Return
+272.89%
AUM
$114M
AUM Growth
+$5.69M
(+5.2%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-15.44%
Top 10 Holdings %
Top 10 Hldgs %
50.18%
Holding
51
New
2
Increased
7
Reduced
35
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Timken Company
TKR
|
+$325K |
| 2 |
Microsoft
MSFT
|
+$277K |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
+$226K |
| 4 |
Bladex Inc
BLX
|
+$98K |
| 5 |
Pure Cycle
PCYO
|
+$24.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Escalade
ESCA
|
+$2.55M |
| 2 |
Liberty Global Class A
LBTYA
|
+$1.9M |
| 3 |
1-800-Flowers.com
FLWS
|
+$1.38M |
| 4 |
Texas Pacific Land
TPL
|
+$755K |
| 5 |
Philips
PHG
|
+$670K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.6% |
| 2 | Materials | 11.31% |
| 3 | Energy | 10.51% |
| 4 | Technology | 9.86% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSB
1
Mesabi Trust
MSB
$320M
| $7.17M | 6.27% |
409,568
-36,207
| -8% | -$564K |
|
2
Johnson & Johnson
JNJ
$609B
| $6.22M | 5.44% |
44,243
-4,392
| -9% | -$640K |
|
|
3
Texas Pacific Land
TPL
$28.7B
| $6.03M | 5.28% |
91,296
-12,285
| -12% | -$755K |
|
4
IBM
IBM
$200B
| $5.74M | 5.02% |
49,712
-5,400
| -10% | -$627K |
|
5
Franco-Nevada
FNV
$38.7B
| $5.66M | 4.95% |
40,550
+140
| +0.3% | +$18.6K |
|
|
ABB
6
DELISTED
ABB Ltd
ABB
| $5.22M | 4.56% |
231,345
-31,975
| -12% | -$615K |
|
|
7
Philips
PHG
$26.2B
| $4.42M | 3.87% |
116,409
-19,258
| -14% | -$670K |
|
8
Pfizer
PFE
$143B
| $4.09M | 3.58% |
131,813
-13,468
| -9% | -$458K |
|
|
9
Bladex Inc
BLX
$2.22B
| $3.93M | 3.43% |
341,395
+8,664
| +3% | +$98K |
|
|
10
1-800-Flowers.com
FLWS
$263M
| $3.75M | 3.28% |
187,260
-70,086
| -27% | -$1.38M |
|
11
AbbVie
ABBV
$450B
| $3.61M | 3.16% |
36,775
-5,075
| -12% | -$447K |
|
12
Autoliv
ALV
$9B
| $3.48M | 3.04% |
53,866
-7,420
| -12% | -$446K |
|
|
SI
13
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $3.45M | 3.02% |
58,517
-8,615
| -13% | -$508K |
|
14
AB InBev
BUD
$156B
| $3.36M | 2.94% |
68,220
-6,295
| -8% | -$294K |
|
15
Wabtec
WAB
$44.5B
| $3.13M | 2.74% |
54,420
-5,650
| -9% | -$320K |
|
16
Berkshire Hathaway Class B
BRK.B
$1.06T
| $3.05M | 2.67% |
17,077
-2,935
| -15% | -$536K |
|
|
17
Berkshire Hathaway Class A
BRK.A
$1.06T
| $2.67M | 2.34% |
10
-1
| -9% | -$274K |
|
18
Merck
MRK
$315B
| $2.18M | 1.9% |
29,518
-3,245
| -10% | -$244K |
|
|
19
Liberty Global Class A
LBTYA
$3.52B
| $2.06M | 1.81% |
94,475
-92,025
| -49% | -$1.9M |
|
20
Helmerich & Payne
HP
$3.41B
| $1.94M | 1.69% |
99,333
-11,765
| -11% | -$229K |
|
21
Bristol-Myers Squibb
BMY
$124B
| $1.88M | 1.65% |
32,045
-5,125
| -14% | -$307K |
|
22
BP
BP
$108B
| $1.74M | 1.52% |
74,670
-7,895
| -10% | -$189K |
|
|
BMY.RT
23
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.68M | 1.47% |
477,858
-16,025
| -3% | -$57.8K |
|
|
24
Escalade
ESCA
$266M
| $1.4M | 1.22% |
100,146
-274,701
| -73% | -$2.55M |
|
|
RDS.B
25
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.38M | 1.21% |
45,270
-3,635
| -7% | -$119K |
|
Similar funds
MCP
FCIS
SCM
GFA
RA
OI
GFG
EFA
Beddow Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Beddow Capital Management held 51 positions worth $114M, up 5.2% from $109M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Beddow Capital Management withdrew a net $17.7M in Q2 2020, closing 2 positions and reducing 35 holdings. Its most notable exit was Forty Seven, Inc. Common Stock, an estimated $417K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Materials and Energy.
Against the trend, Beddow Capital Management opened a new position in Microsoft worth $310K.
- Beddow Capital Management's largest Q2 2020 buy was Microsoft: 1,525 shares worth $310K.
- Beddow Capital Management added most to Timken Company in Q2 2020, an estimated $325K increase.
- Beddow Capital Management's biggest Q2 2020 reduction was Escalade, cutting an estimated $2.55M.
- Beddow Capital Management fully exited Forty Seven, Inc. Common Stock in Q2 2020, selling an estimated $417K.
- Beddow Capital Management's ten largest holdings make up 50% of its $114M portfolio in Q2 2020.
- Beddow Capital Management opened 2 new positions and closed 2 in Q2 2020.
- Beddow Capital Management's portfolio value rose 5.2% quarter-over-quarter to $114M.
Based on Beddow Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.